论文部分内容阅读
目的 :分析布地奈德联合盐酸氨溴索雾化吸入治疗小儿喘息性支气管炎的疗效情况。方法 :选择我院2013年6月-2015年10月74例喘息性支气管炎患儿,按照治疗方法将其分为两组,即对照组及观察组,各37例;对照组应用盐酸氨溴索治疗,观察组在对照组基础上采用布地奈德治疗,治疗1周后,比较两组临床疗效、血气分析好转情况及不良反应发生率。结果 :观察组临床总有效率达94.6%,明显高于对照组75.7%(P<0.05);观察组Pa O2、Pa CO2、FEV1改善情况明显优于对照组(P<0.05)。结论 :应用布地奈德联合盐酸氨溴索雾化吸入治疗小儿喘息性支气管炎效果好,可有效缓解患者症状,安全性高。
OBJECTIVE: To analyze the efficacy of budesonide combined with ambroxol hydrochloride inhalation in the treatment of infantile asthmatic bronchitis. Methods: 74 children with asthmatic bronchitis were selected from June 2013 to October 2015 in our hospital. According to the treatment, they were divided into two groups, namely, control group and observation group, 37 cases in each group. Control group was treated with ambroxol hydrochloride Cable treatment, the observation group was treated with budesonide on the basis of the control group. After one week of treatment, the clinical curative effect, the improvement of blood gas analysis and the incidence of adverse reactions were compared. Results: The total clinical effective rate in the observation group was 94.6%, which was significantly higher than that in the control group (75.7%, P <0.05). The improvement of PaO2, PaCO2 and FEV1 in the observation group was significantly better than that in the control group (P <0.05). Conclusion: Budesonide combined with ambroxol hydrochloride inhalation is effective in infantile asthmatic bronchitis, which can effectively relieve the symptoms of patients with high safety.